Hydroxychloroquine in obstetric antiphospholipid syndrome: rationale and results of an observational study of refractory cases-Reference-Cited by-同舟云学术

Hydroxychloroquine in obstetric antiphospholipid syndrome: rationale and results of an observational study of refractory cases

Published:2021-05-27 Issue: Volume: Page:1-8
ISSN:1476-7058
Container-title:The Journal of Maternal-Fetal & Neonatal Medicine
language:en
Short-container-title:The Journal of Maternal-Fetal & Neonatal Medicine

Author:

Khizroeva Jamilya¹^ORCID,Bitsadze Victoria¹^ORCID,Tincani Angela¹²^ORCID,Makatsariya Alexander¹^ORCID,Arslanbekova Madina¹,Babaeva Nigar¹,Tsibizova Valentina³^ORCID,Shkoda Andrei⁴^ORCID,Makatsariya Natalya¹,Tretyakova Maria¹^ORCID,Solopova Antonina¹^ORCID,Gadaeva Zumrad¹,Vorobev Alexander¹^ORCID,Khamani Inessa¹,Aslanova Zamilya¹,Nakaidze Inga¹,Mischenko Alexander¹,Grigoreva Kristina¹,Kunesko Nart⁵,Egorova Elena¹,Mashkova Tamara¹

Affiliation:

1. The First I.M. Sechenov Moscow State Medical University (Sechenov University), Moscow, Russia

2. Unit of Rheumatology and Clinical Immunology, ASST Spedali Civili, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy

3. Almazov National Medical Research Centre, Saint Petersburg, Health Ministry of Russian Federation, Saint Petersburg, Russia

4. Moscow Healthcare Department, Moscow, Russia

5. Moscow’s Department of Health, Center for family planning and reproduction (CPSIR), Moscow, Russia

Funder

First I.M. Sechenov Moscow State Medical University

Publisher

Informa UK Limited

Subject

Obstetrics and Gynecology,Pediatrics, Perinatology and Child Health

Link

https://www.tandfonline.com/doi/pdf/10.1080/14767058.2021.1908992

Reference34 articles.